Pharmacological Activity and Clinical Use of PDRN. - Wikidata - wikimedia - TriplyDB

Pharmacological Activity and Clinical Use of PDRN.

Pharmacological Activity and Clinical Use of PDRN.

http://www.wikidata.org/entity/Q33603413

about

Activation of A2A Receptor by PDRN Reduces Neuronal Damage and Stimulates WNT/β-CATENIN Driven Neurogenesis in Spinal Cord Injury.Usefulness of polydeoxyribonucleotide as an alternative to corticosteroids in patients with lateral epicondyitis: A case series.

P2860

Q55262715-6B5B9EB4-A0FA-4411-B456-3AC1087F59FC Q55456379-FE6C4CBF-5C71-4489-897C-8134AE72F2B2

P2860

Pharmacological Activity and Clinical Use of PDRN.

http://www.wikidata.org/entity/Q33603413

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Pharmacological Activity and Clinical Use of PDRN.

@ast

Pharmacological Activity and Clinical Use of PDRN.

@en

type

label

Pharmacological Activity and Clinical Use of PDRN.

@ast

Pharmacological Activity and Clinical Use of PDRN.

@en

prefLabel

Pharmacological Activity and Clinical Use of PDRN.

@ast

Pharmacological Activity and Clinical Use of PDRN.

@en

P1433

Q33603413-427570DF-90E9-4AD1-B544-32EC3E5A793C

P1476

Q33603413-28A35B4E-D56A-4B68-8526-608C704CD9F7

P2093

Q33603413-39537E17-DE0A-4EF8-8522-DDEDF03D79E4

Q33603413-854AE049-1BD9-43AF-BCC0-B2FE52A7400F

Q33603413-9EC6208E-4D99-4474-A5AA-4DE22FB654F8

Q33603413-AC7C1F62-614D-4CBB-9B22-E3A60540D306

Q33603413-E69C8D30-8544-4643-ABBE-26D6FE07B63B

Q33603413-EA50381A-2916-431D-9E99-BEB17897D094

Q33603413-F674CD25-22DC-4DF8-BC42-85DF077BEFF3

P2860

Q33603413-034D84D6-DD85-436F-85DC-4ADDDA109BB0

Q33603413-0FE725D7-971B-4674-92C8-D8E3F763FA37

Q33603413-1009063C-3736-426A-8C0A-DA29E67E6D03

Q33603413-102EE226-EA3B-4E05-A75A-21132F1E593E

Q33603413-1238CADB-9DEF-43B8-B516-F2E55D70E11B

Q33603413-19B3BE91-C6C5-4068-A4DB-1C125D84AD22

Q33603413-29E7E114-8582-462A-86F7-D11D745ED635

Q33603413-3486B889-C314-4968-A5C2-F1C7C2FFA65E

Q33603413-3535BE59-DBB2-4371-AAC4-EB7665DBA592

Q33603413-474D0872-FB67-42F9-A16D-DFEAB86E1EFA

P304

Q33603413-B93F8180-52DE-4E09-9081-A67E6EDC1E0E

P31

Q33603413-395C49CE-B094-4E85-AC7A-3E4D444D8677

P356

Q33603413-F04B2374-4F32-463F-9CFD-7A860E56B207

P478

Q33603413-34893607-C690-4D3B-A3B3-A58A5F54A7F8

P577

Q33603413-EA5A1669-AB72-4B5E-B19B-18444C707DAC

P698

Q33603413-6B9D8CAE-B996-4AB2-B797-ACB7AE2B3ACC

P932

Q33603413-736C572B-2807-4D2C-9E6F-442D3364A39E

P356

FPHAR.2017.00224

P1433

Frontiers in Pharmacology

P1476

Pharmacological Activity and Clinical Use of PDRN.

@en

P2093

Alessandra Bitto

http://www.w3.org/2001/XMLSchema#string

Domenica Altavilla

http://www.w3.org/2001/XMLSchema#string

Francesco Squadrito

http://www.w3.org/2001/XMLSchema#string

Gabriele Pizzino

http://www.w3.org/2001/XMLSchema#string

Giovanni Pallio

http://www.w3.org/2001/XMLSchema#string

Letteria Minutoli

http://www.w3.org/2001/XMLSchema#string

Natasha Irrera

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical evaluation of corneal epithelialization after photorefractive keratectomy in patients treated with polydeoxyribonucleotide (PDRN) eye drops: a randomized, double-blind, placebo-controlled trial.

Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease.

Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps.

Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.

Update on the use of defibrotide.

Wound healing and its impairment in the diabetic foot.

The molecular biology of chronic wounds and delayed healing in diabetes.

The effects of polydeoxyribonucleotide on the survival of random pattern skin flaps in rats.

Polydeoxyribonucleotide Dermal Infiltration in Male Genital Lichen Sclerosus: Adjuvant Effects during Topical Therapy.

Regadenoson: a new myocardial stress agent.

P304

224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00224

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28491036

http://www.w3.org/2001/XMLSchema#string

P932

5405115

http://www.w3.org/2001/XMLSchema#string